Palazestrant
Palazestrant (OP-1250) is an orally available and highly potent estrogen receptor antagonist and selective ER degrader with antitumor activity.Palazestrant inhibits 17b-estradiol (E2), inhibits MCF7 and CAMA-1 cell proliferation, and can be used in breast cancer research.
Product Specifications
CAS Number
2092925-89-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
449.6
Molecular Formula
C28H36FN3O
Notes
Research use only, not for human use.
Receptor
Estrogen/progestogen Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
413459-01 100 mg
2- (3-Isothiocyanatophenyl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Ask
View Details 
413459-02 250 mg
2- (3-Isothiocyanatophenyl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Ask
View Details 
SIPM593Mu01-01 10 µg
Recombinant Leucine Rich Repeats And Immunoglobulin Like Domains Protein 3 (LRIG3)
Ask
View Details